A Multi-Center, Open-Label Pharmacokinetic and Safety Study for Reduction in Fever or Management of Pain in Pediatric Subjects Aged Birth to Six Months
Phase of Trial: Phase IV
Latest Information Update: 12 Jan 2018
At a glance
- Drugs Ibuprofen (Primary)
- Indications Fever; Pain
- Focus Pharmacokinetics
- Sponsors Cumberland Pharmaceuticals
- 08 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 08 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 18 Jul 2017 Status changed from not yet recruiting to recruiting.